PEDESAP Pediatric ESAP Live

Program: ESAP Live
Clinical Session
Sunday, April 3, 2016: 11:45 AM-1:15 PM
Room 153 (BCEC)
Speakers:
Andrew Jacob Bauer, MD, The Children's Hospital of Philadelphia, Philadelphia, PA , Mark Daniel DeBoer, MD, MSc., MCR, Univ of Virginia, Charlottesville, VA , Paola Palma Sisto, MD, University of Connecticut, Farmington, CT , Bradley Scott Miller, MD, PhD, University of Minnesota Masonic Children's Hospital, Minneapolis, MN , Lawrence A. Silverman, MD, Goryeb Children's Hospital, Morristown, NJ , Craig Alan Alter, MD, Children's Hospital of Philadelphia, Huntingdon Valley, PA and Stephen H LaFranchi, MD, OR Health Sciences Univ, Portland, OR
Moderator:
Rachel Ilana Gafni, MD, National Institute of Dental and Craniofacial Research/NIH, Bethesda, MD

Disclosures:
RIG: Investigator, Shire. CAA: Advisory Group Member, Pfizer, Inc.. Nothing to Disclose: MDD Disclosure Not Provided: AJB, PP, BSM, LAS, SHL

New to ENDO is the extension of ESAP Live to our pediatric-focused attendees. Add Pediatric ESAP 2015-2016 during registration to receive a discounted rate, and join expert faculty at ENDO to learn directly from the authors of this ABPapproved MOC activity.

In addition to AMA PRA Category 1 Credits, this session will be approved for ABP MOC Part 2 points.

See more of: ESAP Live

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire